Trial Profile
The effect of levosimendan, on renal blood flow, function and oxygen uptake during acute renal failure after cardiac surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2021
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Renal failure; Renal impairment
- Focus Pharmacodynamics
- Acronyms Levo-AKI; LEVOAKI
- 17 Mar 2021 Status changed from recruiting to completed.
- 02 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 02 Apr 2019 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2020.